Topic Listing for MAKO SURGICAL CORP

Acceleration Equity Accounting Derivative Financial Instruments Indexed Potentially Settled Own
Accounting Income Taxes Accounting Nonrefundable Advance Payments Goods Services Received Future
Accrual Warranty Costs Acquisitions Assets Predecessor
Adjustments Adopted Accounting Pronouncements
Adverse Changes Economic Conditions Reduced Spending Innovative Medical Advertising Costs
Allowance Doubtful Accounts Amendment
Amendment Amended Employment Agreement Annual Cash Compensation
Annual Meeting Stockholders 2009 Anti-kickback Statutes Federal False Claims Act
Art Attempt Acquire New Products Technologies Unable Successfully Complete
Audit Committee Audit Committee Report
Available Information Background
Background Proposal Base Salary
Basis Presentation Basis Presentation Estimates
Bear Cost Soliciting Votes Meeting Because Markets Products Highly Competitive Customers Choose Purchase
Become Subject Patent Other Intellectual Property Litigation Costly Become Subject Product Liability Claims Actions Including Recalls
Beneficial Ownership Reporting Compliance Benny Hagag
Board Committees Meetings Board Representation
Business Combinations Business Highlights
Business Milestones Conditions Exercise Call Right Business Overview
Call Right Warrants Issued Closing Cash Bonuses
Cash Equivalents Certain Directors Executive Officers Key Employees Interest Z-kat
Certification Change Control Arrangements
Change Vote Charles Federico
Christopher Dewey Class Director Nominees Election Three-year Term Expiring 2011
Class Director Nominees Election Three-year Term Expiring 2012 Class Directors Term Expiring 2009 Annual Meeting Stockholders
Class Directors Term Expiring 2010 Annual Meeting Stockholders Class Directors Term Expiring 2011 Annual Meeting Stockholders
Clearance Pathway Clinical Trials
Closing Commercial Insurers
Commitments Contingencies Committees
Common Stock Communications Audit Committees
Communications Board Directors Compared 2006
Compared 2007 Comparison 2009 2008
Compensation Committee Compensation Committee Report
Compensation Philosophy Objectives Competition
Comprehensive Loss Concentrations Credit Risk Other Risks Uncertainties
Conference Call Contact
Contingencies Contractual Obligations
Controls Procedures Corporate Governance Nominating Committee
Cost Revenue Covenants
Critical Accounting Policies Critical Accounting Policies Significant Judgments Estimates
Current Credit Financial Market Conditions Delay Prevent Customers Current Orthopedic Knee Arthroplasty Approaches
Currently Required Fda Refrain Using Certain Terms Label Deadline Receipt Stockholder Proposals
Deferred Initial Public Offering Costs Deferred Revenue Cost
Departure Directors Certain Officers Election Appointment Compensatory Depend Key Employees Fail Attract Retain Expertise Required
Depend Success Single Line Products Revenue Impair Ability Depreciation Amortization
Description Business Determination Stock-based Compensation
Determining Fair Value Financial Asset Market Not Active Determining Fair Value Volume Level Activity Asset Liability
Determining Whether Instrument Embedded Feature Indexed Entitys Own Did Sale Issuance Shares Common Stock Warrants Purchase
Director Compensation Disposable Products
Dividend Policy Documents Incorporated Reference
Duncan Moffat Early Versions Tactile Guidance System
Early-stage Medical Device Limited Operating History Business Not Earnings Call Information
Earnings Per Share Ection Beneficial Ownership Reporting Compliance
Effect Accounting Tax Treatment Compensation Decisions Effect Failure Obtain Stockholder Approval Proposal
Effect Stockholder Approval Proposal Elements Executive Compensation Program
Employee Loans Employee Stock Purchase Plan
Employees Employment Agreements
Eneral Information Equity Compensation Plan Information
Exchange Act 1934 Amendment Executive Compensation
Executive Officers Executive Officers Key Employees
Exercise Warrants Exhibits
Expect Price Common Stock Fluctuate Substantially Lead Losses Factors Influence Future Results Operations
Fail Comply Extensive Government Regulations Relating Business Subject Failure Efforts Train Surgeons Hospital Staff Result Lower
Failure Obtain Regulatory Approval Additional Foreign Jurisdictions Prevent Fair Value Financial Instruments
Fair Value Measurements Fda Premarket Clearance Approval Requirements
Federal Regulatory Reforms Adversely Affect Ability Sell Products Ferré
Financial Review Financial Statements Exhibits
Find Information Find Voting Results Annual Meeting
Fort Lauderdale Fort Lauderdale Florida 33317
Forward-looking Statements Fraud Abuse Laws
Frederic Moll Fritz Laporte
Full Financial Review Fundamental Transactions
Future Potential Applications General Information
Gerald Brunk Growing Osteoarthritis Problem
Healthcare Reforms Changes Policies Third-party Coverage Reimbursements Affect Hipaa Other Fraud Privacy Regulations
Hospitals Surgeons Other Healthcare Providers Unable Obtain Coverage Ibm License Agreement
Ignatures Impairment Long-lived Assets
Income Taxes Incorporation Reference
Incurred Significant Losses Since Inception Anticipate Continue Incur Independent Directors
Index Index Current Report Form 8-k Dated 2009
Index Form 10-k Index Form 10-q
Initial Closing Intangible Assets
Intellectual Property Interest Certain Parties Closing
Interest Other Expense Interest Other Expenses
Interest Other Income International Marketing Approvals
Introduction Introduction Minimally Invasive Surgery
Introduction Robotics Other Surgical Fields Inventory
Inventory Valuation Investments
Issuer Purchases Equity Securities Key Employees
Knee Makoplasty Solution Not Gain Market Acceptance Able Lauderdale Florida 33317
Legal Proceedings License Arrangements Other Parties
License Arrangements Z-kat License Royalty Agreements
Likely Continue Experience Extended Variable Sales Cycles Together Limited Experience Assembling Testing Products Encounter Problems Delays
Limited Sales Marketing Experience Capabilities Impair Ability Achieve Liquidity Capital Resources
Liquidity Operations Long-term Equity Compensation
Majority Stockholders Already Agreed Vote Favor Proposal Issuance Mako Robotic Arm System
Mako Solution Mako Surgical Corp
Mako Surgical Corp 7000000 Shares Mako Surgical Corp Appoints Senior Vice President Strategic
Mako Surgical Corp Bank New York Mellon Bny Mako Surgical Corp Reports Operating Results 2009
Makoplasty Solution Managements Report Internal Control Over Financial Reporting
Manufacturing Assembly Marcelo Chao
Market Information Market Osteoarthritis Knee
Market Overview Maurice Ferré
Medicare Medicaid Meetings Attendance
Menashe Frank Messrs Laporte Abovitz Frank Nunes
Messrs Laporte Abovitz Moffat Frank Modifications Currently Fda Cleared Products Introduction New Require
Morry Blumenfeld Phd Nasdaq Stockholder Approval Requirements
Negative Worldwide Economic Conditions Long Lead Times Required Net Cash Provided Financing Activities
Net Cash Provided Used Investing Activities Net Cash Used Investing Activities
Net Cash Used Operating Activities Net Loss Per Share
New Accounting Pronouncements Nine-month Financial Review
Nomination Process Nominees Directors Continuing Office
Noncontrolling Interests Consolidated Financial Statements Not Effectively Manage Growth Unable Successfully Develop Market
Not Paid Dividends Past Expect Pay Foreseeable Future Not Sufficient Funding Complete Development Commercialization Existing Products
Not Timely Achieve Development Goals New Products Commercialization Notice Annual Meeting Stockholders
Notice Annual Meeting Stockholders Attached Proxy Statement Accompanying Notice Special Meeting Stockholders
Number 001-33966 Off-balance Sheet Arrangements
Only Limited Clinical Data Support Value Knee Makoplasty Operating Capital Expenditure Requirements
Operating Leases Operations Currently Conducted Primarily Single Location Florida Risk
Option Exercises Stock Vested Other Events
Other Matters Overview
Parties License Intellectual Property Unable Secure Maintain Patent Patents Patent Applications Licensed Parties
Performance Graph Perquisites Other Benefits
Pervasive Continuing Regulation Plan
Please Sign Date Return Proxy Card Promptly Using Pma Approval Pathway
Policies Procedures Related Person Transactions Post-market Studies
Pre-approval Policies Procedures Preferred Stock
Principal Accounting Fees Services Principal Stockholders Directors Executive Officers Own Large Percentage
Proceeds Financing Transaction Products
Products Future Subject Product Actions Harm Reputation Business Products Malfunction Cause Contribute Death Serious Injury Subject
Property Equipment Proposed Transaction
Proxy Materials Available Internet Proxy Properly Executed Voted Directed Stockholder Such Directions
Proxy Solicited Behalf Board Directors Proxy Statement Table Contents
Purchase Commitments Quantitative Qualitative Disclosures Market Risk
Ratification Appointment Ernst Young Llp Independent Registered Public Receive Significant Number Warranty Claims Robotic Arm System
Receiving Materials Recent Accounting Pronouncements
Recent Business Developments Recent Business Highlights
Recent Capital Raising Transaction Need Raise Additional Future Recent Sales Preferred Stock
Recitals Reclassifications
Recognition Recognition Presentation Other-than-temporary Impairments
Recommendation Board Directors Redeemable Convertible Preferred Stock
Registration Rights Regulatory Requirements Food Drug Administration
Related Parties Reliance Third-party Suppliers Including Single Source Implants Nearly
Rely Heavily Intellectual Property License Others Unable Maintain Representations Warranties
Research Development Research Development Costs
Research Development Expenses Restoris Family Knee Implant Systems
Restoris Mck Multicompartmental Knee Implant System Restoris Unicompartmental Knee Implant System
Restricted Stock Receivable Related Party Results Operations
Results Operations Financial Condition Revenue
Revenue Recognition Reverse Stock Split Conversion Preferred
Risk Factors Risks Uncertainties
Robotics Orthopedic Surgical Procedures Role Directors Executive Officers Compensation Consultants
Rony Abovitz Sales Marketing
Sales Substantial Number Shares Common Stock Public Market Schedule
Schedule 14a Proxy Statement Pursuant Securities Exchange Act Securities Analysts Issue Negative Reports Cease Cover Common
Securities Purchase Agreement Seeking Stockholder Approval Proposal Issuance Securities Closing
Selected Operating Results Selling General Administrative
Selling General Administrative Expenses Shareholders Subject Lockup
Shares Present Hold Annual Meeting Shares Present Hold Special Meeting
Signature Signatures
Six-month Financial Review Software Development Costs
Software Revenue Recognition Special Meeting Stockholders 2009
Stock Option Plans Stock-based Compensation Stock-based Compensation
Stockholder Proposals Due Next Annual Meeting Strategy
Subject Damages Resulting Claims Employees Consultants Wrongfully Used Subject Damages Resulting Claims Employees Wrongfully Used Disclosed
Subject Directly Indirectly Federal State Healthcare Fraud Abuse Subject Fines Penalties Injunctions Determined Promoting Products Unapproved
Submission Matters Vote Security Holders Subsequent Events
Successful Efforts Market Sell Knee Makoplasty Internationally Subject Summary Securities Purchase Agreement
Summary Significant Accounting Policies Summary Voting Agreements
Summary Warrants Surgeons Hospitals Orthopedic Product Agents Distributors Existing Relationships
Table Contents Tem Controls Procedures
Tem Exhibits Tem Managements Discussion Analysis Financial Condition Results Operations
Tem Quantitative Qualitative Disclosures Market Risk Tem Risk Factors
Tem Submission Matters Vote Security Holders Tem Unregistered Sales Equity Securities Proceeds
Terms Financing Third-party Manufacturers Suppliers Fail Comply Fdas Quality System
Third-party Reimbursement Transition Report Pursuant Securities Exchange Act 1934
Unable Prevent Unauthorized Disclosure Proprietary Trade Secrets Unpatented Uncertainty Income Taxes
United States Securities Exchange Washington 20549 Unregistered Sales Equity Securities
Unregistered Sales Equity Securities Proceeds Uses Proceeds Sale Registered Securities
Valuation Allowance Deferred Income Tax Assets Liabilities Version Tgs Rio System
Vote Vote Annual Meeting
Votes Counted Votes Nominees Director Receive Elected
Votes Proposal Authorization Issue Securities Closing Receive Approved Votes Ratification Appointment Ernst Young Llp Independent Registered
Voting Agreements Warrants
What Mean Receive Proxy Card What Proxy Card
What Securities Did Mako Surgical Corp Issue Initial What Securities Issue Closing Purchase Agreement
What Voting Wholly Owned Patent Applications
William Pruitt William Tapia
Wwwmakosurgicalcom Wwwproxyvotecom
Xhibit Index Yes
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki